BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nakamura H, Tanaka T, Hori S, Yoshioka H, Kuroda C, Okamura J, Sakurai M. Transcatheter embolization of hepatocellular carcinoma: assessment of efficacy in cases of resection following embolization. Radiology. 1983;147:401-405. [PMID: 6300959 DOI: 10.1148/radiology.147.2.6300959] [Cited by in Crossref: 137] [Cited by in F6Publishing: 121] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Ohto M, Kondo F, Ebara M. Pathology, diagnosis, and treatment for small liver cancer. In: Tobe T, Kameda H, Okudaira M, Ohto M, Endo Y, Mito M, Okamoto E, Tanikawa K, Kojiro M, editors. Primary Liver Cancer in Japan. Tokyo: Springer Japan; 1992. pp. 365-73. [DOI: 10.1007/978-4-431-68177-9_36] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
2 Yamashita N, Izumikawa S, Takagi A, Arakawa H, Wakasawa T, Maruyama A. Preparation and characterization of gelatin sponge millispheres from air-in-water-in-oil-type emulsions. J Mater Sci Mater Med 2009;20:1299-305. [PMID: 19132505 DOI: 10.1007/s10856-008-3681-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Wah TM, Arellano RS, Gervais DA, Saltalamacchia CA, Martino J, Halpern EF, Maher M, Mueller PR. Image-guided percutaneous radiofrequency ablation and incidence of post-radiofrequency ablation syndrome: prospective survey. Radiology 2005;237:1097-102. [PMID: 16304121 DOI: 10.1148/radiol.2373042008] [Cited by in Crossref: 55] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
4 Shin SW. The current practice of transarterial chemoembolization for the treatment of hepatocellular carcinoma. Korean J Radiol. 2009;10:425-434. [PMID: 19721826 DOI: 10.3348/kjr.2009.10.5.425] [Cited by in Crossref: 96] [Cited by in F6Publishing: 82] [Article Influence: 8.0] [Reference Citation Analysis]
5 Sun Z, Li G, Ai X, Luo B, Wen Y, Zhao Z, Dong S, Guan J. Hepatic and biliary damage after transarterial chemoembolization for malignant hepatic tumors: incidence, diagnosis, treatment, outcome and mechanism. Crit Rev Oncol Hematol 2011;79:164-74. [PMID: 20719529 DOI: 10.1016/j.critrevonc.2010.07.019] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 3.5] [Reference Citation Analysis]
6 Kanai T, Hirohashi S, Upton MP, Noguchi M, Kishi K, Makuuchi M, Yamasaki S, Hasegawa H, Takayasu K, Moriyama N, Shimosato Y. Pathology of small hepatocellular carcinoma. A proposal for a new gross classification. Cancer 1987;60:810-9. [DOI: 10.1002/1097-0142(19870815)60:4<810::aid-cncr2820600417>3.0.co;2-1] [Cited by in Crossref: 254] [Cited by in F6Publishing: 62] [Article Influence: 7.5] [Reference Citation Analysis]
7 Sugahara S, Oshiro Y, Nakayama H, Fukuda K, Mizumoto M, Abei M, Shoda J, Matsuzaki Y, Thono E, Tokita M. Proton beam therapy for large hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2010;76:460-466. [PMID: 19427743 DOI: 10.1016/j.ijrobp.2009.02.030] [Cited by in Crossref: 80] [Cited by in F6Publishing: 57] [Article Influence: 6.7] [Reference Citation Analysis]
8 Nakagawa N, Cornelius AS, Kao SC, Nakajima Y, Nakada K. Transcatheter Oily Chemoembolization for Unresectable Malignant Liver Tumors in Children. Journal of Vascular and Interventional Radiology 1993;4:353-8. [DOI: 10.1016/s1051-0443(93)71875-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
9 Pelletier G, Roche A, Ink O, Anciaux ML, Derhy S, Rougier P, Lenoir C, Attali P, Etienne JP. A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol. 1990;11:181-184. [PMID: 2174933 DOI: 10.1016/0168-8278(90)90110-d] [Cited by in Crossref: 304] [Cited by in F6Publishing: 57] [Article Influence: 10.1] [Reference Citation Analysis]
10 Yu JS, Kim JH, Chung JJ, Kim KW. Added value of diffusion-weighted imaging in the MRI assessment of perilesional tumor recurrence after chemoembolization of hepatocellular carcinomas. J Magn Reson Imaging. 2009;30:153-160. [PMID: 19557734 DOI: 10.1002/jmri.21818] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 3.6] [Reference Citation Analysis]
11 Hirai K, Kawazoe Y, Yamashita K, Aoki Y, Fujimoto T, Sakai T, Majima Y, Abe M, Tanikawa K. Arterial chemotherapy and transcatheter arterial embolization therapy for non-resectable hepatocellular carcinoma. Cancer Chemother Pharmacol 1989;23:S37-41. [DOI: 10.1007/bf00647237] [Cited by in Crossref: 21] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
12 Murata S, Mine T, Ueda T, Nakazawa K, Onozawa S, Yasui D, Kumita S. Transcatheter arterial chemoembolization based on hepatic hemodynamics for hepatocellular carcinoma. ScientificWorldJournal 2013;2013:479805. [PMID: 23606815 DOI: 10.1155/2013/479805] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
13 Morimoto K, Takatsuka Y, Sugitachi A, Miyata Y, Choi S, Hashimoto T, Hara K. Combined Transcatheter Arterial Embolization and Regional Chemotherapy for Locally Advanced Carcinoma of the Breast: A preliminary investigation. Acta Radiologica: Oncology 2009;24:241-5. [DOI: 10.3109/02841868509134394] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
14 Ohnishi K, Okuda K, Ohtsuki T, Nakayama T, Hiyama Y, Iwama S, Goto N, Nakajima Y, Musha N, Nakashima T. Formation of Hilar Collaterals or Cavernous Transformation After Portal Vein Obstruction by Hepatocellular Carcinoma. Gastroenterology 1984;87:1150-3. [DOI: 10.1016/s0016-5085(84)80077-3] [Cited by in Crossref: 61] [Article Influence: 1.6] [Reference Citation Analysis]
15 Iwazawa J, Ohue S, Kitayama T, Sassa S, Mitani T. C-Arm CT for Assessing Initial Failure of Iodized Oil Accumulation in Chemoembolization of Hepatocellular Carcinoma. American Journal of Roentgenology 2011;197:W337-42. [DOI: 10.2214/ajr.10.5614] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
16 Yamada R, Kishi K, Sonomura T, Tsuda M, Nomura S, Satoh M. Transcatheter arterial embolization in unresectable hepatocellular carcinoma. Cardiovasc Intervent Radiol. 1990;13:135-139. [PMID: 2171771 DOI: 10.1007/bf02575464] [Cited by in Crossref: 64] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
17 Okada S. Transcatheter arterial embolization for advanced hepatocellular carcinoma: the controversy continues. Hepatology. 1998;27:1743-1744. [PMID: 9620352 DOI: 10.1002/hep.510270639] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 1.4] [Reference Citation Analysis]
18 Kunieda K, Seki T, Nakatani S, Wakabayashi M, Shiro T, Inoue K, Sougawa M, Kimura R, Harada K. Implantation treatment method of slow release anticancer doxorubicin containing hydroxyapatite (DOX-HAP) complex. A basic study of a new treatment for hepatic cancer. Br J Cancer. 1993;67:668-673. [PMID: 8471423 DOI: 10.1038/bjc.1993.124] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 0.7] [Reference Citation Analysis]
19 Nishida N, Yamada R, Kishi K, Sonomura T, Yan R, Kimura M, Maeda H, Satoh M. Dose-Dependency of Hepatocellular Necrosis in a Canine Model of Chemoembolization. Journal of Vascular and Interventional Radiology 1994;5:361-6. [DOI: 10.1016/s1051-0443(94)71503-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
20 Hashimoto T, Nakamura H, Hori S, Tomoda K, Nakanishi K, Murakami T, Kozuka T, Monden M, Gotoh M, Kuroda C. Hepatocellular carcinoma: efficacy of transcatheter oily chemoembolization in relation to macroscopic and microscopic patterns of tumor growth among 100 patients with partial hepatectomy. Cardiovasc Intervent Radiol. 1995;18:82-86. [PMID: 7774000 DOI: 10.1007/bf02807227] [Cited by in Crossref: 22] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
21 Vogl TJ, Trapp M, Schroeder H, Mack M, Schuster A, Schmitt J, Neuhaus P, Felix R. Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center. Radiology. 2000;214:349-357. [PMID: 10671580 DOI: 10.1148/radiology.214.2.r00fe06349] [Cited by in Crossref: 125] [Cited by in F6Publishing: 99] [Article Influence: 6.0] [Reference Citation Analysis]
22 Nerenstone SR, Ihde DC, Friedman MA. Clinical trials in primary hepatocellular carcinoma: current status and future directions. Cancer Treat Rev. 1988;15:1-31. [PMID: 2834053 DOI: 10.1016/0305-7372(88)90007-2] [Cited by in Crossref: 149] [Cited by in F6Publishing: 136] [Article Influence: 4.5] [Reference Citation Analysis]
23 Hsu H, Wei T, Tsang Y, Wu M, Lin Y, Chuang S. Histologic assessment of resected hepatocellular carcinoma after transcatheter hepatic arterial embolization. Cancer 1986;57:1184-91. [DOI: 10.1002/1097-0142(19860315)57:6<1184::aid-cncr2820570620>3.0.co;2-9] [Cited by in Crossref: 57] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
24 Oka H, Tamori A, Kuroki T, Kobayashi K, Yamamoto S. Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma. Hepatology. 1994;19:61-66. [PMID: 7506227 DOI: 10.1002/hep.1840190111] [Cited by in Crossref: 244] [Cited by in F6Publishing: 151] [Article Influence: 9.0] [Reference Citation Analysis]
25 Okuda K, Ohnishi K. Prognosis of Hepatocellular Carcinoma. In: Okuda K, Ishak KG, editors. Neoplasms of the Liver. Tokyo: Springer Japan; 1987. pp. 407-15. [DOI: 10.1007/978-4-431-68349-0_33] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
26 Stridbeck H, Ekelund L, Jonsson N. Segmental Hepatic Arterial Occlusion with Absolute Ethanol in Domestic Swine. Acta Radiologica Diagnosis 1984;25:331-5. [DOI: 10.1177/028418518402500414] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
27 Carrafiello G, Laganà D, Ianniello A, Dionigi G, Novario R, Recaldini C, Mangini M, Cuffari S, Fugazzola C. Post-radiofrequency ablation syndrome after percutaneous radiofrequency of abdominal tumours: one centre experience and review of published works. Australas Radiol 2007;51:550-4. [PMID: 17958690 DOI: 10.1111/j.1440-1673.2007.01871.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 3.0] [Reference Citation Analysis]
28 Kawamoto C, Ido K, Isoda N, Nagamine N, Hozumi M, Ono K, Nakazawa Y, Sato Y, Kimura K. Prognosis of small hepatocellular carcinoma after laparoscopic ethanol injection. Gastrointestinal Endoscopy 1999;50:214-20. [DOI: 10.1016/s0016-5107(99)70227-0] [Cited by in Crossref: 7] [Article Influence: 0.3] [Reference Citation Analysis]
29 Vetter D, Wenger J, Bergier J, Doffoel M, Bockel R. Transcatheter oily chemoembolization in the management of advanced hepatocellular carcinoma in cirrhosis: Results of a western comparative study in 60 patients. Hepatology 1991;13:427-33. [DOI: 10.1002/hep.1840130308] [Cited by in Crossref: 105] [Cited by in F6Publishing: 80] [Article Influence: 3.5] [Reference Citation Analysis]
30 Uchida H, Ohishi H, Matsuo N, Nishimine K, Ohue S, Nishimura Y, Maeda M, Yoshioka T. Transcatheter hepatic segmental arterial embolization using lipiodol mixed with an anticancer drug and Gelfoam particles for hepatocellular carcinoma. Cardiovasc Intervent Radiol. 1990;13:140-145. [PMID: 2171772 DOI: 10.1007/bf02575465] [Cited by in Crossref: 141] [Cited by in F6Publishing: 30] [Article Influence: 4.5] [Reference Citation Analysis]
31 Yamakado K, Nakatsuka A, Tanaka N, Matsumura K, Takase K, Takeda K. Long-term Follow-up Arterial Chemoembolization Combined with Transportal Ethanol Injection Used to Treat Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 1999;10:641-7. [DOI: 10.1016/s1051-0443(99)70095-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
32 Hickey RM, Lewandowski RJ, Salem R. Rationale of transcatheter intra-arterial therapies of hepatic cancers. Hepat Oncol 2014;1:285-91. [PMID: 30190963 DOI: 10.2217/hep.14.11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
33 Tajima T, Nishie A, Asayama Y, Ishigami K, Ushijima Y, Kakihara D, Honda H. Safety Margins of Hepatocellular Carcinoma Demonstrated by 3-Dimensional Fused Images of Computed Tomographic Hepatic Arteriography/Unenhanced Computed Tomography: Prognostic Significance in Patients Who Underwent Transcatheter Arterial Chemoembolization. Journal of Computer Assisted Tomography 2010;34:712-9. [DOI: 10.1097/rct.0b013e3181e1d241] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
34 Imaeda T, Yamawaki Y, Seki M, Goto H, Iinuma G, Kanematsu M, Mochizuki R, Doi H, Saji S, Shimokawa K. Lipiodol retention and massive necrosis after lipiodol-chemoembolization of hepatocellular carcinoma: correlation between computed tomography and histopathology. Cardiovasc Intervent Radiol. 1993;16:209-213. [PMID: 8402781 DOI: 10.1007/bf02602962] [Cited by in Crossref: 42] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
35 Sasaki Y, Imaoka S, Kasugai H, Fujita M, Kawamoto S, Ishiguro S, Kojima J, Ishikawa O, Ohigashi H, Furukawa H. A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin, and gelatin sponge. Cancer. 1987;60:1194-1203. [PMID: 2441837 DOI: 10.1002/1097-0142(19870915)60:6%3C1194::AID-CNCR2820600607%3E3.0.CO;2-T] [Reference Citation Analysis]
36 Okazaki M, Higashihara H, Ono H, Koganemaru F, Fujimitsu R, Mizuma Y, Nakamura T, Sato S, Kimura S, Kodama S. Chemoembolization for Hepatocellular Carcinoma via the Inferior Pancreaticoduodenal Artery in Patients with Celiac Artery Stenosis. Acta Radiol 1993;34:20-5. [DOI: 10.1177/028418519303400105] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
37 Kita K, Itoshima T, Tsuji T. Observation of microvascular casts of human hepatocellular carcinoma by scanning electron microscopy. Gastroenterol Jpn 1991;26:319-28. [DOI: 10.1007/bf02781920] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
38 Abada HT, Golzarian J. Gelatine sponge particles: handling characteristics for endovascular use. Tech Vasc Interv Radiol. 2007;10:257-260. [PMID: 18572138 DOI: 10.1053/j.tvir.2008.03.002] [Cited by in Crossref: 47] [Cited by in F6Publishing: 36] [Article Influence: 3.6] [Reference Citation Analysis]
39 Bronowicki JP, Vetter D, Dumas F, Boudjema K, Bader R, Weiss AM, Wenger JJ, Boissel P, Bigard MA, Doffoel M. Transcatheter oily chemoembolization for hepatocellular carcinoma. A 4-year study of 127 French patients. Cancer 1994;74:16-24. [PMID: 7516263 DOI: 10.1002/1097-0142(19940701)74:1<16::aid-cncr2820740105>3.0.co;2-v] [Cited by in Crossref: 120] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
40 Yu YQ, Xu DB, Zhou XD, Lu JZ, Tang ZY, Mack P. Experience with liver resection after hepatic arterial chemoembolization for hepatocellular carcinoma. Cancer 1993;71:62-5. [PMID: 8380123 DOI: 10.1002/1097-0142(19930101)71:1<62::aid-cncr2820710111>3.0.co;2-8] [Cited by in Crossref: 70] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
41 Kobayashi S, Nakanuma Y, Matsui O. Histopathology of portal tracts in livers after transcatheter arterial chemo-embolization therapy for hepatocellular carcinoma. J Gastroenterol Hepatol 1994;9:45-54. [DOI: 10.1111/j.1440-1746.1994.tb01215.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
42 Nakao N, Ishikura R, Miura K, Takahashi H, Miura T. Transcatheter arterial embolization in hepatoma complicated with obstructive jaundice. Cardiovasc Intervent Radiol 1987;10:40-2. [DOI: 10.1007/bf02583306] [Cited by in Crossref: 5] [Article Influence: 0.1] [Reference Citation Analysis]
43 Dong YH, Lin G. Experimental studies of portal venous embolization with iodized oil in rats with experimentally induced liver cancer. J Vasc Interv Radiol 1993;4:621-4. [PMID: 8219556 DOI: 10.1016/s1051-0443(93)71935-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
44 Shiozawa S, Tsuchiya A, Endo S, Kato H, Katsube T, Kumazawa K, Naritaka Y, Ogawa K. Transradial Approach for Transcatheter Arterial Chemoembolization in Patients With Hepatocellular Carcinoma: Comparison with Conventional Transfemoral Approach. Journal of Clinical Gastroenterology 2003;37:412-7. [DOI: 10.1097/00004836-200311000-00013] [Cited by in Crossref: 29] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
45 Nakata K, Khan KN, Nagataki S. Transcatheter arterial embolization of hepatic neoplasms. Critical Reviews in Oncology/Hematology 1992;13:93-105. [DOI: 10.1016/1040-8428(92)90019-m] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
46 Sonomura T, Yamada R, Kishi K, Nishida N, Yang RJ, Sato M. Dependency of tissue necrosis on gelatin sponge particle size after canine hepatic artery embolization. Cardiovasc Intervent Radiol 1997;20:50-3. [DOI: 10.1007/s002709900108] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
47 Shiina S, Teratani T, Obi S, Hamamura K, Koike Y, Omata M. Percutaneous ethanol injection therapy for liver tumors. European Journal of Ultrasound 2001;13:95-106. [DOI: 10.1016/s0929-8266(01)00123-9] [Cited by in Crossref: 28] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
48 Bismuth H, Morino M, Sherlock D, Castaing D, Miglietta C, Cauquil P, Roche A. Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg. 1992;163:387-394. [PMID: 1373044 DOI: 10.1016/0002-9610(92)90039-t] [Cited by in Crossref: 200] [Cited by in F6Publishing: 40] [Article Influence: 6.9] [Reference Citation Analysis]
49 Tam KY, Leung KC, Wang YX. Chemoembolization agents for cancer treatment. Eur J Pharm Sci 2011;44:1-10. [PMID: 21726636 DOI: 10.1016/j.ejps.2011.06.013] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 4.1] [Reference Citation Analysis]
50 Chen MF, Jan YY, Lee TY. Transcatheter hepatic arterial embolization followed by hepatic resection for the spontaneous rupture of hepatocellular carcinoma. Cancer 1986;58:332-5. [PMID: 3013390 DOI: 10.1002/1097-0142(19860715)58:2<332::aid-cncr2820580221>3.0.co;2-u] [Cited by in Crossref: 27] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
51 Yamada R, Kishi K, Terada M, Sonomura T, Sato M. Transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma. In: Tobe T, Kameda H, Okudaira M, Ohto M, Endo Y, Mito M, Okamoto E, Tanikawa K, Kojiro M, editors. Primary Liver Cancer in Japan. Tokyo: Springer Japan; 1992. pp. 259-71. [DOI: 10.1007/978-4-431-68177-9_25] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
52 Qian J. Interventional therapies of unresectable liver metastases. J Cancer Res Clin Oncol 2011;137:1763-72. [DOI: 10.1007/s00432-011-1026-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
53 Ohto M, Yoshikawa M, Saisho H, Ebara M, Sugiura N. Nonsurgical treatment of hepatocellular carcinoma in cirrhotic patients. World J Surg 1995;19:42-6. [PMID: 7740809 DOI: 10.1007/BF00316978] [Cited by in Crossref: 32] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
54 Tung-Ping Poon R, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg. 2000;232:10-24. [PMID: 10862190 DOI: 10.1097/00000658-200007000-00003] [Cited by in Crossref: 551] [Cited by in F6Publishing: 518] [Article Influence: 26.2] [Reference Citation Analysis]
55 Yamada R, Kishi K, Sato M, Sonomura T, Nishida N, Tanaka K, Shioyama Y, Terada M, Kimura M. Transcatheter arterial chemoembolization (TACE) in the treatment of unresectable liver cancer. World J Surg. 1995;19:795-800. [PMID: 8553668 DOI: 10.1007/bf00299773] [Cited by in Crossref: 39] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
56 Pleguezuelo M, Marelli L, Misseri M, Germani G, Calvaruso V, Xiruochakis E, Pinelopi M, Burroughs AK. TACE versus TAE as therapy for hepatocellular carcinoma. Expert Rev Anticancer Ther. 2008;8:1623-1641. [PMID: 18925854 DOI: 10.1586/14737140.8.10.1623] [Cited by in Crossref: 56] [Cited by in F6Publishing: 46] [Article Influence: 4.7] [Reference Citation Analysis]
57 Yang CF, Ho YZ, Chang JM, Chiang RH, Lai KH, Lee SD, Tsai YT, Lui WY, Liu TJ, Chen GH. Transcatheter arterial chemoembolization for hepatocellular carcinoma. Cancer Chemother Pharmacol 1989;23 Suppl:S26-8. [PMID: 2538261 DOI: 10.1007/BF00647234] [Cited by in Crossref: 16] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
58 Matsui O, Kawamura I, Kadoya M, Takashima T, Nakanuma Y. Hepatic artery embolization of experimental hepatic tumors with absolute ethanol. Cardiovasc Intervent Radiol 1986;9:146-51. [DOI: 10.1007/bf02577925] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
59 Zhang YW, Ao J, Liu Y, Qiao MX, Yang XL, Tang SX, Li C, Xu K. Pharmacokinetics of gelatin sponge microparticles in a rabbit VX2 liver tumor model of hepatic arterial chemoembolization. Tumour Biol 2014;35:10905-10. [PMID: 25085588 DOI: 10.1007/s13277-014-2408-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
60 Tateishi H, Kinuta M, Furukawa J, Takata N, Maruyama H, Oi H, Yayoi E, Okamura J. Follow-up study of combination treatment (TAE and PEIT) for unresectable hepatocellular carcinoma. Cancer Chemother Pharmacol 1994;33:S119-23. [DOI: 10.1007/bf00686682] [Cited by in Crossref: 9] [Article Influence: 0.3] [Reference Citation Analysis]
61 Nakamura H, Hashimoto T, Oi H, Sawada S. Balloon-occluded arterial portography using prostaglandin E1: Improved visualization of the intrahepatic portal vein. Cardiovasc Intervent Radiol 1987;10:264-8. [DOI: 10.1007/bf02578006] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
62 Nouchi T, Nishimura M, Maeda M, Funatsu T, Hasumura Y, Takeuchi J. Transcatheter arterial embolization of ruptured hepatocellular carcinoma associated with liver cirrhosis. Dig Dis Sci. 1984;29:1137-1141. [PMID: 6094127 DOI: 10.1007/bf01317089] [Cited by in Crossref: 24] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
63 Lewandowski RJ, Geschwind JF, Liapi E, Salem R. Transcatheter intraarterial therapies: rationale and overview. Radiology 2011;259:641-57. [PMID: 21602502 DOI: 10.1148/radiol.11081489] [Cited by in Crossref: 140] [Cited by in F6Publishing: 114] [Article Influence: 14.0] [Reference Citation Analysis]
64 Miki I, Murata S, Uchiyama F, Yasui D, Ueda T, Sugihara F, Saito H, Yamaguchi H, Murakami R, Kawamoto C, Uchida E, Kumita SI. Evaluation of the relationship between hepatocellular carcinoma location and transarterial chemoembolization efficacy. World J Gastroenterol 2017;23:6437-47. [PMID: 29085193 DOI: 10.3748/wjg.v23.i35.6437] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
65 Dover RW, Ferrier AJ, Torode HW. Sarcomas and the conservative management of uterine fibroids: a cause for concern? Aust N Z J Obstet Gynaecol 2000;40:308-12. [PMID: 11065039 DOI: 10.1111/j.1479-828x.2000.tb03340.x] [Cited by in Crossref: 8] [Article Influence: 0.4] [Reference Citation Analysis]
66 Sakurai M, Okamura J, Kuroda C. Transcatheter chemo-embolization effective for treating hepatocellular carcinoma. A histopathologic study. Cancer 1984;54:387-92. [DOI: 10.1002/1097-0142(19840801)54:3<387::aid-cncr2820540303>3.0.co;2-w] [Cited by in Crossref: 125] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
67 Shimada R, Imamura H, Makuuchi M, Soeda J, Kobayashi A, Noike T, Miyagawa S, Kawasaki S. Staged hepatectomy after emergency transcatheter arterial embolization for ruptured hepatocellular carcinoma. Surgery. 1998;124:526-535. [PMID: 9736905 DOI: 10.1016/S0039-6060(98)70099-6] [Cited by in Crossref: 34] [Article Influence: 1.5] [Reference Citation Analysis]
68 Nagasue N, Kohno H, Uchida M. Evaluation of preoperative transcatheter arterial embolization in the treatment of resectable primary liver cancer. Semin Surg Oncol 1993;9:327-31. [DOI: 10.1002/ssu.2980090409] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.3] [Reference Citation Analysis]
69 Chen R, Lii J, Chen W, Tu H, Chiang L. Transcatheter arterial chemoembolization in patients with hepatocellular carcinoma and coexisting hepatic cavernous hemangioma. Eur Radiol 2006;16:1346-50. [DOI: 10.1007/s00330-005-0074-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
70 Young S, Craig P, Golzarian J. Current trends in the treatment of hepatocellular carcinoma with transarterial embolization: a cross-sectional survey of techniques. Eur Radiol 2019;29:3287-95. [DOI: 10.1007/s00330-018-5782-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
71 Farinati F, De Maria N, Marafin C, Herszènyi L, Del Prato S, Rinaldi M, Perini L, Cardin R, Naccarato R. Unresectable hepatocellular carcinoma in cirrhosis: survival, prognostic factors, and unexpected side effects after transcatheter arterial chemoembolization. Dig Dis Sci. 1996;41:2332-2339. [PMID: 9011438 DOI: 10.1007/bf02100123] [Cited by in Crossref: 54] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
72 Audisio RA, Doci R, Mazzaferro V, Bellegotti L, Tommasini M, Montalto F, Marchianò A, Piva A, Defazio C, Damascelli B, Gennari L, van Thiel DH. hepatic arterial embolization with microencapsulated mitomycin C for unresectable hepatocellular carcinoma in cirrhosis. Cancer 1990;66:228-36. [DOI: 10.1002/1097-0142(19900715)66:2<228::aid-cncr2820660206>3.0.co;2-g] [Cited by in Crossref: 18] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
73 Cho YZ, Park SY, Choi EH, Baik SK, Kwon SO, Kim YJ, Cha SH, Kim MY. The usefulness of contrast-enhanced ultrasonography in the early detection of hepatocellular carcinoma viability after transarterial chemoembolization: pilot study. Clin Mol Hepatol 2015;21:165-74. [PMID: 26157754 DOI: 10.3350/cmh.2015.21.2.165] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
74 Allgaier HP, Deibert P, Olschewski M, Spamer C, Blum U, Gerok W, Blum HE. Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injection--a single-center analysis including 132 patients. Int J Cancer 1998;79:601-5. [PMID: 9842968 DOI: 10.1002/(sici)1097-0215(19981218)79:6<601::aid-ijc8>3.0.co;2-f] [Cited by in Crossref: 83] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
75 Sasaki Y, Imaoka S, Kasugai H, Fujita M, Kawamoto S, Ishiguro S, Kojima J, Ishikawa O, Ohigashi H, Furukawa H. A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin, and gelatin sponge. Cancer 1987;60:1194-203. [PMID: 2441837 DOI: 10.1002/1097-0142(19870915)60:6<1194::aid-cncr2820600607>3.0.co;2-t] [Cited by in Crossref: 185] [Cited by in F6Publishing: 34] [Article Influence: 5.4] [Reference Citation Analysis]
76 Nagasue N, Galizia G, Kohno H, Chang Y, Hayashi T, Yamanoi A, Nakamura T, Yukaya H. Adverse effects of preoperative hepatic artery chemoembolization for resectable hepatocellular carcinoma: A retrospective comparison of 138 liver resections. British Journal of Surgery 1989;76:871-6. [DOI: 10.1002/bjs.1800760836] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
77 Nakamura H, Hashimoto T, Oi H, Furui S, Sawada S, Mizumoto S, Monden M. Treatment of Hepatocellular Carcinoma by Segmental Hepatic Artery Injection of Adriamycin-In-Oil Emulsion with Overflow to Segmental Portal Veins. Acta Radiol 1990;31:347-9. [DOI: 10.1177/028418519003100405] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 3.8] [Reference Citation Analysis]
78 Huo T, Lee S. Management of inoperable hepatocellular carcinoma. J Gastroenterol Hepatol 2004;19:S272-8. [DOI: 10.1111/j.1440-1746.2004.03686.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
79 Kim YI, Chung JW. Selective or targeted gene/drug delivery for liver tumors: advantages and current status of local delivery. Expert Rev Gastroenterol Hepatol 2008;2:791-802. [PMID: 19090739 DOI: 10.1586/17474124.2.6.791] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
80 Gross-Goupil M, Saffroy R, Azoulay D, Precetti S, Emile JF, Delvart V, Tindilière F, Laurent A, Bellin MF, Bismuth H. Real-time quantification of AFP mRNA to assess hematogenous dissemination after transarterial chemoembolization of hepatocellular carcinoma. Ann Surg. 2003;238:241-248. [PMID: 12894018 DOI: 10.1097/01.sla.0000080959.95226.be] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
81 Marelli L, Stigliano R, Triantos C, Senzolo M, Cholongitas E, Davies N, Tibballs J, Meyer T, Patch DW, Burroughs AK. Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol. 2007;30:6-25. [PMID: 17103105 DOI: 10.1007/s00270-006-0062-3] [Cited by in Crossref: 552] [Cited by in F6Publishing: 451] [Article Influence: 39.4] [Reference Citation Analysis]
82 Kaibori M, Tanigawa N, Kariya S, Ikeda H, Nakahashi Y, Hirohara J, Koreeda C, Seki T, Sawada S, Okazaki K, Kwon AH. A prospective randomized controlled trial of preoperative whole-liver chemolipiodolization for hepatocellular carcinoma. Dig Dis Sci 2012;57:1404-12. [PMID: 22271410 DOI: 10.1007/s10620-012-2029-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
83 Huo T, Huang Y, Wu J, Lee P, Chang F, Lee S. Induction of complete tumor necrosis may reduce intrahepatic metastasis and prolong survival in patients with hepatocellular carcinoma undergoing locoregional therapy: a prospective study. Annals of Oncology 2004;15:775-80. [DOI: 10.1093/annonc/mdh184] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
84 Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H, Nakajima Y, Ohnishi K. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer. 1985;56:918-928. [PMID: 2990661 DOI: 10.1002/1097-0142(19850815)56:4%3C918::AID-CNCR2820560437%3E3.0.CO;2-E] [Reference Citation Analysis]
85 Kim YI, Chung JW, Park JH, Han JK, Hong JW, Chung H. Intraarterial gene delivery in rabbit hepatic tumors: transfection with nonviral vector by using iodized oil emulsion. Radiology. 2006;240:771-777. [PMID: 16857983 DOI: 10.1148/radiol.2403051261] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
86 Uflacker R, Paolini RM, Nobrega M. Ablation of Tumor and Inflammatory Tissue with Absolute Ethanol. Acta Radiologica Diagnosis 1986;27:131-8. [DOI: 10.1177/028418518602700202] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
87 Pelletier G, Ducreux M, Gay F, Luboinski M, Hagège H, Dao T, Van Steenbergen W, Buffet C, Rougier P, Adler M. Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC. J Hepatol. 1998;29:129-134. [PMID: 9696501 DOI: 10.1016/s0168-8278(98)80187-6] [Cited by in Crossref: 284] [Cited by in F6Publishing: 70] [Article Influence: 12.3] [Reference Citation Analysis]
88 Nishimine K, Uchida H, Matsuo N, Sakaguchi H, Hirohashi S, Nishimura Y, Guo Q, Ohishi H, Nagano N, Yoshioka T. Segmental transarterial chemoembolization with Lipiodol mixed with anticancer drugs for nonresectable hepatocellular carcinoma: follow-up CT and therapeutic results. Cancer Chemother Pharmacol. 1994;33 Suppl:S60-S68. [PMID: 7511069 DOI: 10.1007/bf00686670] [Cited by in Crossref: 47] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
89 Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H, Nakajima Y, Ohnishi K. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 1985;56:918-28. [PMID: 2990661 DOI: 10.1002/1097-0142(19850815)56:4<918::aid-cncr2820560437>3.0.co;2-e] [Cited by in Crossref: 1291] [Cited by in F6Publishing: 378] [Article Influence: 35.9] [Reference Citation Analysis]
90 Kim HJ, Kim TK, Kim PN, Kim AY, Ko EY, Kim KW, Sung K, Ha HK, Kim HC, Lee M. Assessment of the Therapeutic Response of Hepatocellular Carcinoma Treated With Transcatheter Arterial Chemoembolization: Comparison of Contrast-Enhanced Sonography and 3-Phase Computed Tomography. Journal of Ultrasound in Medicine 2006;25:477-86. [DOI: 10.7863/jum.2006.25.4.477] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
91 Nakao N, Uchida H, Kamino K, Nishimura Y, Ohishi H, Takayasu Y, Nakamura H, Kuroda C, Fujita M, Yoshioka H. Effectiveness of Lipiodol in transcatheter arterial embolization of hepatocellular carcinoma. Cancer Chemother Pharmacol 1992;31 Suppl:S72-6. [PMID: 1333913 DOI: 10.1007/BF00687110] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
92 Komada Y, Murata S, Tajima H, Kumita S, Kanazawa H, Tajiri T. Haemodynamic changes in the liver under balloon occlusion of a portal vein branch: evaluation with single-level dynamic computed tomography during hepatic arteriography. Clin Radiol. 2007;62:579-586. [PMID: 17467396 DOI: 10.1016/j.crad.2007.01.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
93 Tanaka K, Nakamura S, Numata K, Kondo M, Morita K, Kitamura T, Saito S, Kiba T, Okazaki H, Sekihara H. The long term efficacy of combined transcatheter arterial embolization and percutaneous ethanol injection in the treatment of patients with large hepatocellular carcinoma and cirrhosis. Cancer 1998;82:78-85. [PMID: 9428482 DOI: 10.1002/(sici)1097-0142(19980101)82:1<78::aid-cncr9>3.0.co;2-g] [Cited by in Crossref: 54] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
94 Hasuike Y, Okamura J, Furukawa J, Naoi M, Takata N, Maruyama H, Kinuta M, Yayoi E, Oi H, Okamoto S, Monden M, Mori T, Sakurai M. Efficacy of combination treatment ? (TAE with adriamycin and ethanol) ? for hepatocellular carcinoma. Cancer Chemother Pharmacol 1992;31:S30-4. [DOI: 10.1007/bf00687101] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
95 Okada S. How to manage hepatic vein tumour thrombus in hepatocellular carcinoma. J Gastroenterol Hepatol. 2000;15:346-348. [PMID: 10824876 DOI: 10.1046/j.1440-1746.2000.02151.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.1] [Reference Citation Analysis]
96 Shibayama Y. Role of endotoxaemia in the development of hepatic failure following hepatic artery occlusion. J Pathol 1990;161:321-5. [DOI: 10.1002/path.1711610408] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
97 Miraglia R, Pietrosi G, Maruzzelli L, Petridis I, Caruso S, Marrone G, Mamone G, Vizzini G, Luca A, Gridelli B. Predictive factors of tumor response to trans-catheter treatment in cirrhotic patients with hepatocellular carcinoma: a multivariate analysis of pre-treatment findings. World J Gastroenterol 2007;13:6022-6. [PMID: 18023093 DOI: 10.3748/wjg.v13.45.6022] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
98 Bruix J, Castells A, Montanyà X, Calvet X, Brü C, Ayuso C, Jover L, García L, Vilana R, Boix L, Rodés J. Phase II study of transarterial embolization in european patients with hepatocellular carcinoma: Need for controlled trials. Hepatology 1994;20:643-50. [DOI: 10.1002/hep.1840200315] [Cited by in Crossref: 61] [Cited by in F6Publishing: 46] [Article Influence: 2.3] [Reference Citation Analysis]
99 Shibata T, Yamamoto K, Hayashi N, Yonekura Y, Nagara T, Saji H, Mukai T, Konishi J. Dynamic positron emission tomography with 13N-ammonia in liver tumors. Eur J Nucl Med 1988;14:607-11. [PMID: 2854065 DOI: 10.1007/BF00251784] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
100 Wanebo HJ, Vezeridis MP. Hepatoma. J Surg Oncol 1993;53:40-5. [DOI: 10.1002/jso.2930530512] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
101 Young N, Hollands M, Wong KP. Symptom relief and survival after chemo-embolization with adriamycin, lipiodol and gelfoam for hepatocellular carcinoma. Australas Radiol. 1993;37:173-176. [PMID: 8390237 DOI: 10.1111/j.1440-1673.1993.tb00044.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
102 Loewe C, Cejna M, Schoder M, Thurnher MM, Lammer J, Thurnher SA. Arterial embolization of unresectable hepatocellular carcinoma with use of cyanoacrylate and lipiodol. J Vasc Interv Radiol. 2002;13:61-69. [PMID: 11788696 DOI: 10.1016/s1051-0443(07)60010-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
103 Yoshida T, Sakon M, Umeshita K, Kanai T, Miyamoto A, Takeda T, Gotoh M, Nakamura H, Wakasa K, Monden M. Appraisal of transarterial immunoembolization for hepatocellular carcinoma: a clinicopathologic study. J Clin Gastroenterol. 2001;32:59-65. [PMID: 11154173 DOI: 10.1097/00004836-200101000-00014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
104 Murata S, Mine T, Sugihara F, Yasui D, Yamaguchi H, Ueda T, Onozawa S, Kumita S. Interventional treatment for unresectable hepatocellular carcinoma. World J Gastroenterol. 2014;20:13453-13465. [PMID: 25309076 DOI: 10.3748/wjg.v20.i37.13453] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
105 Kumada T, Nakano S, Takeda I, Sugiyama K, Osada T, Kiriyama S, Yamada M, Okabe H. Treatment of small hepatocellular carcinoma. Cancer Chemother Pharmacol 1992;31:S25-9. [DOI: 10.1007/bf00687100] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
106 Yamakado K, Takeda K, Nishide Y, Jin J, Matsumura K, Nakatsuka A, Hirano T, Kato N, Nakagawa T. Portal vein embolization with steel coils and absolute ethanol: A comparative experimental study with canine liver. Hepatology 1995;22:1812-8. [DOI: 10.1002/hep.1840220630] [Cited by in Crossref: 36] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
107 Takayasu K, Muramatsu Y, Moriyama N, Wakao F. Hepatic angiography in hepatocellular carcinoma: status among modern imaging modalities and its role as a further examination. In: Tobe T, Kameda H, Okudaira M, Ohto M, Endo Y, Mito M, Okamoto E, Tanikawa K, Kojiro M, editors. Primary Liver Cancer in Japan. Tokyo: Springer Japan; 1992. pp. 153-60. [DOI: 10.1007/978-4-431-68177-9_15] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
108 Oi H, Kim T, Kishimoto H, Matsushita M, Tateishi H, Okamura J. Effective cases of transcatheter arterioportal chemoembolization with high-dose iodized oil for hepatocellular carcinoma. Cancer Chemother Pharmacol. 1994;33 Suppl:S69-S73. [PMID: 8137486 DOI: 10.1007/bf00686671] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
109 Habib A, Desai K, Hickey R, Thornburg B, Lewandowski R, Salem R. Transarterial approaches to primary and secondary hepatic malignancies. Nat Rev Clin Oncol 2015;12:481-9. [PMID: 25985939 DOI: 10.1038/nrclinonc.2015.78] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
110 Chern MC, Chuang VP, Cheng T, Lin ZH, Lin YM. Transcatheter arterial chemoembolization for advanced hepatocellular carcinoma with inferior vena cava and right atrial tumors. Cardiovasc Intervent Radiol. 2008;31:735-744. [PMID: 18427894 DOI: 10.1007/s00270-008-9342-4] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
111 Joyce AD, Howard ER. Hepatobiliary Tumours of Childhood: Investigation and Management. In: Spitz L, Wurnig P, Angerpointner TA, editors. Pediatric Surgical Oncology. Berlin: Springer Berlin Heidelberg; 1989. pp. 69-93. [DOI: 10.1007/978-3-642-72643-9_5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
112 Molinari M, Kachura JR, Dixon E, Rajan DK, Hayeems EB, Asch MR, Benjamin MS, Sherman M, Gallinger S, Burnett B. Transarterial chemoembolisation for advanced hepatocellular carcinoma: results from a North American cancer centre. Clin Oncol (R Coll Radiol). 2006;18:684-692. [PMID: 17100154 DOI: 10.1016/j.clon.2006.07.012] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
113 Nakamura H, Kondoh H. Emphysematous cholecystitis: Complication of hepatic artery embolization. Cardiovasc Intervent Radiol 1986;9:152-3. [DOI: 10.1007/bf02577926] [Cited by in Crossref: 15] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
114 Adachi E, Matsumata T, Nishizaki T, Hashimoto H, Tsuneyoshi M, Sugimachi K. Effects of preoperative transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma. The relationship between postoperative course and tumor necrosis. Cancer 1993;72:3593-8. [PMID: 8252473 DOI: 10.1002/1097-0142(19931215)72:12<3593::aid-cncr2820721208>3.0.co;2-t] [Cited by in Crossref: 88] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
115 Huo T, Huang Y, Wu J, Chiang J, Lee P, Chang F, Lee S. Comparison of transarterial chemoembolization and percutaneous acetic acid injection as the primary loco-regional therapy for unresectable hepatocellular carcinoma: a prospective survey: UNRESECTABLE HEPATOCELLULAR CARCINOMA TREATMENT. Alimentary Pharmacology & Therapeutics 2004;19:1301-8. [DOI: 10.1111/j.1365-2036.2004.01996.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
116 Nakamura H, Mitani T, Murakami T, Hashimoto T, Tsuda K, Nakanishi K, Ishida T, Tomoda K, Hori S, Kozuka T. Five-year survival after transcatheter chemoembolization for hepatocellular carcinoma. Cancer Chemother Pharmacol. 1994;33 Suppl:S89-S92. [PMID: 8137491 DOI: 10.1007/bf00686675] [Cited by in Crossref: 38] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
117 Sakamoto N, Monzawa S, Nagano H, Nishizaki H, Arai Y, Sugimura K. Acute Tumor Lysis Syndrome Caused by Transcatheter Oily Chemoembolization in a Patient with a Large Hepatocellular Carcinoma. Cardiovasc Intervent Radiol 2007;30:508-11. [DOI: 10.1007/s00270-005-0240-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
118 Araki T, Hihara T, Kachi K, Matsusako M, Ito M, Kohno K, Uchiyama G. Newly developed transarterial chemoembolization material: CDDP—lipiodol suspension. Gastrointest Radiol 1989;14:46-8. [DOI: 10.1007/bf01889153] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
119 Trevisani F, De Notariis S, Rossi C, Bernardi M. Randomized control trials on chemoembolization for hepatocellular carcinoma: is there room for new studies? J Clin Gastroenterol. 2001;32:383-389. [PMID: 11319307 DOI: 10.1097/00004836-200105000-00005] [Cited by in Crossref: 82] [Cited by in F6Publishing: 74] [Article Influence: 4.1] [Reference Citation Analysis]
120 Jun Q, Gansheng F, Trübenbach J, Pereira PL, Huppert PE, Claussen CD. Experimentelle Untersuchung zur Effektivität der Transarteriellen Chemoembolisation (TACE) im Tiermodell des hepatozellulären Karzinoms. Journal of Tongji Medical University 2001;21:115-8. [DOI: 10.1007/bf02888072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
121 Petrelli NJ, Mittelman A. Hepatic Artery Ligation for Liver Cancer. In: Bottino JC, Opfell RW, Muggia FM, editors. Liver Cancer. Boston: Springer US; 1985. pp. 143-56. [DOI: 10.1007/978-1-4613-2593-2_7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]